Myriad Genetics Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Myriad Genetics personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs

Company Highlights
Year Founded

1991

icon-altEmployees

2,621

Location (HQ)

USA

Since Last Funding

1 year 4 months

Monthly Website Visitors

235.1K

icon-altTotal Investment Amt

$90M

Last Funding Round

Post Ipo Debt

icon-altMoM Headcount Growth

0.46%

icon-altYoY Headcount Growth

4.63%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology

Biotechnology Research

Pharmaceutical

Precision Medicine